Chronic Wound Treatment Clinical Guidelines & Case Studies

Data & Results You Can See And Trust

Our product philosophy is rooted in proven efficacy. We have selected our products based on their ability to deliver excellent, measurable patient outcomes. Below are the clinical guidelines for using our amniotic membrane grafts and documented case studies demonstrating their effectiveness in practice.

Aligned With
Medical Research

We align our services with the broader medical and research community. Research published by the NCBI highlights that bioengineered skin substitutes are critical tools for complex chronic wounds.

"The AM [Amniotic Membrane] Has A Crucial Function As A Medicinal Agent Used To Treat Various Dermatological Cases, Demonstrating Its Ability To Promote Skin Regeneration."

Our dedication to an evidence-based model ensures that the products we provide are innovative, clinically appropriate, and effective.

Guidelines For Treatment Success

A successful outcome begins with appropriate patient and wound selection. Based on Medicare guidelines, the following characteristics define a viable chronic wound prepared for advanced graft treatment.

Wound History

The wound must be chronic (at least 30 days old) and have failed to respond to prior conservative treatments.

Wound Condition

It must be a full-thickness, infection-free wound without any exposed tendon, capsule, or bone.

Wound Viability

The wound must be a minimum of 1 cm² and have adequate circulation to support healing.

Documented Patient Outcomes

We measure our success by the success of our provider partners and their patients. Here are several documented outcomes that showcase the efficacy of our chronic wound treatment solutions.